T. E. ÇETİN Et Al. , "Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis," ESMO Congress 2023 , Madrid, Spain, 2023
ÇETİN, T. E. Et Al. 2023. Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis. ESMO Congress 2023 , (Madrid, Spain).
ÇETİN, T. E., SÜTCÜOĞLU, O., ÜNER, A., GÜNEL, N., SAVAŞ, G., ÖZDEMİR, N., ... YAZICI, O.(2023). Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis . ESMO Congress 2023, Madrid, Spain
ÇETİN, TAHA Et Al. "Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis," ESMO Congress 2023, Madrid, Spain, 2023
ÇETİN, TAHA E. Et Al. "Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis." ESMO Congress 2023 , Madrid, Spain, 2023
ÇETİN, T. E. Et Al. (2023) . "Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis." ESMO Congress 2023 , Madrid, Spain.
@conferencepaper{conferencepaper, author={TAHA ENES ÇETİN Et Al. }, title={Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis}, congress name={ESMO Congress 2023}, city={Madrid}, country={Spain}, year={2023}}